World's Best Scientists 2026 revealed!
Award Badge
Genetics
France
2024

D-Index & Metrics

Genetics

D-Index
71
Citations
17742
World Ranking
2200
National Ranking
99

Charles Theillet publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Charles Theillet sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 178 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Charles Theillet D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Charles Theillet sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 71 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Research.com Recognitions

  • 2024 - Research.com Genetics in France Leader Award

Overview

Charles Theillet is affiliated with the University of Montpellier in France, contributing primarily to the fields of Biochemistry, Genetics and Molecular Biology as well as Medicine. Their research spans a total of 31 publications in biochemistry, genetics, and molecular biology, alongside 21 papers in medical sciences. Within these broad disciplines, Theillet has developed expertise in subfields including Molecular Biology, Oncology, Genetics, Cell Biology, and Radiology, Nuclear Medicine and Imaging.

Theillet's research addresses several main topics related to cancer biology and molecular mechanisms. These include:

  • DNA Repair Mechanisms
  • PARP inhibition in cancer therapy
  • Genomics and Chromatin Dynamics
  • BRCA gene mutations in cancer
  • Epigenetics and DNA Methylation
  • Cancer-related Molecular Pathways
  • Monoclonal and Polyclonal Antibodies Research

Frequent coauthors collaborating with Theillet are William Jacot, Béatrice Orsetti, Esin Orhan, Carolina Velázquez, and Imène Tabet, reflecting ongoing partnerships in related molecular oncology and genetics research.

Theillet has published in several venues, including bioRxiv (Cold Spring Harbor Laboratory) with 4 publications, Cancers with 2 papers, as well as the International Journal of Molecular Sciences and Pancreatology each featuring 2 contributions. They also published work in Nature Communications.

Recent papers provide insight into the thematic breadth and specific focuses of Theillet's research:

  • "A predictable conserved DNA base composition signature defines human core DNA replication origins," 2020, Nature Communications
  • "BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer," 2020, Cancers
  • "Regulation of RAD51 at the Transcriptional and Functional Levels: What Prospects for Cancer Therapy?", 2021, Cancers
  • "Targeting MDM2-dependent serine metabolism as a therapeutic strategy for liposarcoma," 2020, Science Translational Medicine
  • "In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2," 2022, The Journal of Pathology

Best Publications

  • International network of cancer genome projects

    Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker

  • The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

    Magali Olivier;Anita Langerød;Patrizia Carrieri;Jonas Bergh

  • Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.

    Chantal Escot;Charles Theillet;Rosette Lidereau;Frederique Spyratos

  • Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription

    Sandie Tuduri;Sandie Tuduri;Laure Crabbé;Chiara Conti;Hélène Tourrière

  • EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer

    Luke Hughes-Davies;David Huntsman;Margarida Ruas;Francois Fuks

  • Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia

    Iqbal Unnisa Ali;Rosette Lidereau;Charles Theillet;Robert Callahan

  • BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.

    Adnane J;Gaudray P;Dionne Ca;Crumley G

  • A refined molecular taxonomy of breast cancer

    M Guedj;L Marisa;A de Reynies;B Orsetti

  • Snail and Slug Play Distinct Roles during Breast Carcinoma Progression

    Christophe Côme;Fabrice Magnino;Frédéric Bibeau;Pascal De Santa Barbara

  • In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.

    S Bautista;H Vallès;R L Walker;S Anzick

  • Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.

    Frank Courjal;Marguerite Cuny;Joelle Simony-Lafontaine;Geneviève Louason

  • Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.

    Charles Theillet;Rosette Lidereau;Chantal Escot;Paula Hutzell

  • Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer

    Véronique Gelsi-Boyer;Béatrice Orsetti;Nathalie Cervera;Pascal Finetti

  • Protocols for an improved detection of point mutations by SSCP

    Laura Spinardi;Raoul Mazars;Charles Theillet

  • p53 gene mutations in human epithelial skin cancers.

    J P Molès;C Moyret;B Guillot;P Jeanteur

  • Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors

    Frank Courjal;Geneviève Louason;Paul Speiser;Dionisios Katsaros

  • Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene

    Selma El Messaoudi;Eric Fabbrizio;Carmen Rodriguez;Paul Chuchana

  • A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer

    Maïa Chanrion;Vincent Negre;Hélène Fontaine;Nicolas Salvetat

  • TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains

    Anne‐Lise ‐L Børresen;Tone Ikdahl Andersen;Jorunn E. Eyfjörd;Renee S. Cornelis

  • Proto-oncogene amplification and human breast tumor phenotype.

    J Adnane;P Gaudray;M P Simon;J Simony-Lafontaine

Frequent Co-Authors

Rosette Lidereau
Rosette Lidereau Institute Curie
Jocelyne Jacquemier
Jocelyne Jacquemier Grenoble Alpes University
Robert Callahan
Robert Callahan National Institutes of Health
Evgeny N. Imyanitov
Evgeny N. Imyanitov Pacific Institute of Bioorganic Chemistry. GB Elyakova Far Eastern Branch of the Russian Academy of Sciences
Jacques Colinge
Jacques Colinge University of Montpellier
André Pèlegrin
André Pèlegrin University of Montpellier
Claude Sardet
Claude Sardet University of Montpellier
Dionyssios Katsaros
Dionyssios Katsaros University of Turin
Richard Redon
Richard Redon University of Nantes

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Genetics, there are several online degree and certification options that can help you carve out a fulfilling career. For students eager to work in healthcare, medical coding programs offer a foundational understanding of medical data—knowledge that can complement genetics studies, especially for those seeking roles in research management or biomedical fields.

Many learners value flexibility and speed when advancing their education. accelerated degree programs allow motivated students to complete their studies faster, helping them enter the workforce or pursue graduate research with minimal delay.

Alternatively, those balancing work or family commitments may consider a self paced online degree, which lets students learn at their own rhythm. Coupling this with opportunities from universities with no application fee can make further education more accessible and affordable.

Whether you’re charting a new career or enhancing your credentials, these flexible online pathways offer affordable routes into genetics and related fields.

Best Scientists Citing Charles Theillet

Trending Scientists

Recently Published Articles